TY - STD TI - WHO. World Malaria Report 2015. Geneva, World Health Organization, 2015. http://www.whoint/malaria/publications/world-malaria-report-2015/report/en/. 2015. UR - http://www.whoint/malaria/publications/world-malaria-report-2015/report/en/ ID - ref1 ER - TY - JOUR PY - 2011 DA - 2011// TI - A research agenda for malaria eradication: drugs JO - PLoS Med. VL - 8 UR - https://doi.org/10.1371/journal.pmed.1000402 DO - 10.1371/journal.pmed.1000402 ID - ref2 ER - TY - STD TI - WHO. Global Technical Strategy for Malaria 2016–2030. Geneva, World Health Organization. http://www.whoint/malaria/areas/global_technical_strategy/en/. 2016. UR - http://www.whoint/malaria/areas/global_technical_strategy/en/ ID - ref3 ER - TY - JOUR AU - Burrows, J. N. AU - Hooft van Huijsduijnen, R. AU - Möhrle, J. J. AU - Oeuvray, C. AU - Wells, T. N. C. PY - 2013 DA - 2013// TI - Designing the next generation of medicines for malaria control and eradication JO - Malar J. VL - 12 UR - https://doi.org/10.1186/1475-2875-12-187 DO - 10.1186/1475-2875-12-187 ID - Burrows2013 ER - TY - STD TI - USFDA. Guidance for industry and review staff target product profile—a strategic development process tool. Draft guidance. http://www.fdagov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm080593pdf. 2007. UR - http://www.fdagov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm080593pdf ID - ref5 ER - TY - JOUR AU - Wells, T. N. C. AU - Hooft van Huijsduijnen, R. AU - Voorhis, W. C. PY - 2015 DA - 2015// TI - Malaria medicines: a glass half full? JO - Nat Rev Drug Discov. VL - 14 UR - https://doi.org/10.1038/nrd4573 DO - 10.1038/nrd4573 ID - Wells2015 ER - TY - JOUR AU - Phyo, A. P. AU - Jittamala, P. AU - Nosten, F. H. AU - Pukrittayakamee, S. AU - Imwong, M. AU - White, N. J. PY - 2016 DA - 2016// TI - Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial JO - Lancet Infect Dis. VL - 16 UR - https://doi.org/10.1016/S1473-3099(15)00320-5 DO - 10.1016/S1473-3099(15)00320-5 ID - Phyo2016 ER - TY - JOUR AU - White, N. J. AU - Pukrittayakamee, S. AU - Phyo, A. P. AU - Rueangweerayut, R. AU - Nosten, F. AU - Jittamala, P. PY - 2014 DA - 2014// TI - Spiroindolone KAE609 for falciparum and vivax malaria JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1315860 DO - 10.1056/NEJMoa1315860 ID - White2014 ER - TY - JOUR AU - Leong, F. J. AU - Zhao, R. AU - Zeng, S. AU - Magnusson, B. AU - Diagana, T. T. AU - Pertel, P. PY - 2014 DA - 2014// TI - A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers JO - Antimicrob Agents Chemother VL - 58 UR - https://doi.org/10.1128/AAC.03478-14 DO - 10.1128/AAC.03478-14 ID - Leong2014 ER - TY - JOUR AU - White, N. J. AU - Duong, T. T. AU - Uthaisin, C. AU - Nosten, F. AU - Phyo, A. P. AU - Hanboonkunupakarn, B. PY - 2016 DA - 2016// TI - Antimalarial activity of KAF156 in falciparum and vivax malaria JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1602250 DO - 10.1056/NEJMoa1602250 ID - White2016 ER - TY - JOUR AU - Phillips, M. A. AU - Lotharius, J. AU - Marsh, K. AU - White, J. AU - Dayan, A. AU - White, K. L. PY - 2015 DA - 2015// TI - A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria JO - Sci Transl Med. VL - 7 UR - https://doi.org/10.1126/scitranslmed.aaa6645 DO - 10.1126/scitranslmed.aaa6645 ID - Phillips2015 ER - TY - JOUR AU - Ariey, F. AU - Witkowski, B. AU - Amaratunga, C. AU - Beghain, J. AU - Langlois, A. C. AU - Khim, N. PY - 2014 DA - 2014// TI - A molecular marker of artemisinin-resistant Plasmodium falciparum malaria JO - Nature VL - 505 UR - https://doi.org/10.1038/nature12876 DO - 10.1038/nature12876 ID - Ariey2014 ER - TY - JOUR AU - Amaratunga, C. AU - Lim, P. AU - Suon, S. AU - Sreng, S. AU - Mao, S. AU - Sopha, C. PY - 2016 DA - 2016// TI - Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study JO - Lancet Infect Dis. VL - 16 UR - https://doi.org/10.1016/S1473-3099(15)00487-9 DO - 10.1016/S1473-3099(15)00487-9 ID - Amaratunga2016 ER - TY - JOUR AU - Leang, R. AU - Taylor, W. R. AU - Bouth, D. M. AU - Song, L. AU - Tarning, J. AU - Char, M. C. PY - 2015 DA - 2015// TI - Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: dihydroartemisinin–piperaquine open-label multicenter clinical assessment JO - Antimicrob Agents Chemother VL - 59 UR - https://doi.org/10.1128/AAC.00835-15 DO - 10.1128/AAC.00835-15 ID - Leang2015 ER - TY - JOUR AU - Tacoli, C. AU - Gai, P. P. AU - Bayingana, C. AU - Sifft, K. AU - Geus, D. AU - Ndoli, J. PY - 2016 DA - 2016// TI - Artemisinin resistance-associated K13 polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010–2015 JO - Am J Trop Med Hyg VL - 95 UR - https://doi.org/10.4269/ajtmh.16-0483 DO - 10.4269/ajtmh.16-0483 ID - Tacoli2016 ER - TY - JOUR AU - Chen, I. AU - Clarke, S. E. AU - Gosling, R. AU - Hamainza, B. AU - Killeen, G. AU - Magill, A. PY - 2016 DA - 2016// TI - “Asymptomatic” malaria: a chronic and debilitating infection that should be treated JO - PLoS Med. VL - 13 UR - https://doi.org/10.1371/journal.pmed.1001942 DO - 10.1371/journal.pmed.1001942 ID - Chen2016 ER - TY - STD TI - WHO. Single dose Primaquine as a gametocytocide in Plasmodium falciparum malaria: updated WHO policy recommendation (2012). http://www.whoint/malaria/pq_updated_policy_recommendation_en_102012pdf. 2012. UR - http://www.whoint/malaria/pq_updated_policy_recommendation_en_102012pdf ID - ref17 ER - TY - JOUR AU - Chaccour, C. AU - Killeen, G. F. PY - 2016 DA - 2016// TI - Mind the gap: residual malaria transmission, veterinary endectocides and livestock as targets for malaria vector control JO - Malar J. VL - 15 UR - https://doi.org/10.1186/s12936-015-1063-y DO - 10.1186/s12936-015-1063-y ID - Chaccour2016 ER - TY - STD TI - http://www.endmalaria2040.org. UR - http://www.endmalaria2040.org ID - ref19 ER - TY - JOUR AU - Ndiaye, J. L. AU - Randrianarivelojosia, M. AU - Sagara, I. AU - Brasseur, P. AU - Ndiaye, I. AU - Faye, B. PY - 2009 DA - 2009// TI - Randomized, multicentre assessment of the efficacy and safety of ASAQ—a fixed-dose artesunate–amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria JO - Malar J. VL - 8 UR - https://doi.org/10.1186/1475-2875-8-125 DO - 10.1186/1475-2875-8-125 ID - Ndiaye2009 ER - TY - JOUR AU - Sagara, I. AU - Beavogui, A. H. AU - Zongo, I. AU - Soulama, I. AU - Borghini-Fuhrer, I. AU - Fofana, B. PY - 2016 DA - 2016// TI - Safety and efficacy of re-treatments with pyronaridine–artesunate in African patients with malaria: a substudy of the WANECAM randomised trial JO - Lancet Infect Dis. VL - 16 UR - https://doi.org/10.1016/S1473-3099(15)00318-7 DO - 10.1016/S1473-3099(15)00318-7 ID - Sagara2016 ER - TY - JOUR AU - Khatib, R. A. AU - Selemani, M. AU - Mrisho, G. A. AU - Masanja, I. M. AU - Amuri, M. AU - Njozi, M. H. PY - 2013 DA - 2013// TI - Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania JO - Malar J. VL - 12 UR - https://doi.org/10.1186/1475-2875-12-155 DO - 10.1186/1475-2875-12-155 ID - Khatib2013 ER - TY - JOUR AU - Hastings, I. M. AU - Hodel, E. M. AU - Kay, K. PY - 2016 DA - 2016// TI - Quantifying the pharmacology of antimalarial drug combination therapy JO - Sci Rep. VL - 6 UR - https://doi.org/10.1038/srep32762 DO - 10.1038/srep32762 ID - Hastings2016 ER - TY - JOUR AU - Valecha, N. AU - Looareesuwan, S. AU - Martensson, A. AU - Abdulla, S. M. AU - Krudsood, S. AU - Tangpukdee, N. PY - 2010 DA - 2010// TI - Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial JO - Clin Infect Dis VL - 51 UR - https://doi.org/10.1086/655831 DO - 10.1086/655831 ID - Valecha2010 ER - TY - JOUR AU - Stein, D. S. AU - Jain, J. P. AU - Kangas, M. AU - Lefevre, G. AU - Machineni, S. AU - Griffin, P. PY - 2015 DA - 2015// TI - Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (Cipargamin) and piperaquine JO - Antimicrob Agents Chemother VL - 59 UR - https://doi.org/10.1128/AAC.00340-15 DO - 10.1128/AAC.00340-15 ID - Stein2015 ER - TY - JOUR AU - McCarthy, J. S. AU - Baker, M. AU - O’Rourke, P. AU - Marquart, L. AU - Griffin, P. AU - Hooft van Huijsduijnen, R. PY - 2016 DA - 2016// TI - Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers JO - J Antimicrob Chemother VL - 71 UR - https://doi.org/10.1093/jac/dkw174 DO - 10.1093/jac/dkw174 ID - McCarthy2016 ER - TY - JOUR AU - McCarthy, J. S. AU - Lotharius, J. AU - Dayan, A. AU - Phillips, M. AU - Marsh, K. AU - Walker, D. PY - 2014 DA - 2014// TI - A phase I/Ib study to investigate the safety, tolerability and pharmacokinetic profile of DSM265 in healthy subjects and then its antimalarial activity in induced blood stage Plasmodium falciparum infection JO - ASTMH Ann. Meet. VL - 675 ID - McCarthy2014 ER - TY - STD TI - Rückle T, Duparc S, Kerr N, Rosario M, Qiu P, Phillips MA, et al. A phase IIa proof-of-concept study to assess the efficacy, safety, tolerability and pharmacokinetics of single doses of DSM265 in adult patients with acute, uncomplicated Plasmodium falciparum or vivax malaria mono-infection over a 28-day-extended observation period in Iquitos, Peru. In: ASTMH Annual Meeting. 2014;857. Philadelphia, USA, 2015. ID - ref28 ER - TY - JOUR AU - Held, J. AU - Supan, C. AU - Salazar, C. L. AU - Tinto, H. AU - Bonkian, L. N. AU - Nahum, A. PY - 2015 DA - 2015// TI - Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study JO - Lancet Infect Dis. VL - 15 UR - https://doi.org/10.1016/S1473-3099(15)00079-1 DO - 10.1016/S1473-3099(15)00079-1 ID - Held2015 ER - TY - JOUR AU - McCarthy, J. S. AU - Marquart, L. AU - Sekuloski, S. AU - Trenholme, K. AU - Elliott, S. AU - Griffin, P. PY - 2016 DA - 2016// TI - Linking murine and human Plasmodium falciparum challenge models in a translational path for antimalarial drug development JO - Antimicrob Agents Chemother VL - 60 UR - https://doi.org/10.1128/AAC.02883-15 DO - 10.1128/AAC.02883-15 ID - McCarthy2016 ER - TY - JOUR AU - Zani, B. AU - Gathu, M. AU - Donegan, S. AU - Olliaro, P. L. AU - Sinclair, D. PY - 2014 DA - 2014// TI - Dihydroartemisinin–piperaquine for treating uncomplicated Plasmodium falciparum malaria JO - Cochrane Database Syst Rev. VL - 1 ID - Zani2014 ER - TY - JOUR AU - Baiden, R. AU - Oduro, A. AU - Halidou, T. AU - Gyapong, M. AU - Sie, A. AU - Macete, E. PY - 2015 DA - 2015// TI - Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim(R) (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania JO - Malar J. VL - 14 UR - https://doi.org/10.1186/s12936-015-0664-9 DO - 10.1186/s12936-015-0664-9 ID - Baiden2015 ER - TY - JOUR AU - Duparc, S. AU - Borghini-Fuhrer, I. AU - Craft, C. J. AU - Arbe-Barnes, S. AU - Miller, R. M. AU - Shin, C. S. PY - 2013 DA - 2013// TI - Safety and efficacy of pyronaridine–artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials JO - Malar J. VL - 12 UR - https://doi.org/10.1186/1475-2875-12-70 DO - 10.1186/1475-2875-12-70 ID - Duparc2013 ER - TY - JOUR AU - Griffin, J. B. AU - Lokomba, V. AU - Landis, S. H. AU - Thorp, J. M. AU - Herring, A. H. AU - Tshefu, A. K. PY - 2012 DA - 2012// TI - Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study JO - Malar J. VL - 11 UR - https://doi.org/10.1186/1475-2875-11-319 DO - 10.1186/1475-2875-11-319 ID - Griffin2012 ER - TY - JOUR AU - Nambozi, M. AU - Geertruyden, J. P. AU - Hachizovu, S. AU - Chaponda, M. AU - Mukwamataba, D. AU - Mulenga, M. PY - 2011 DA - 2011// TI - Safety and efficacy of dihydroartemisinin–piperaquine versus artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children JO - Malar J. VL - 10 UR - https://doi.org/10.1186/1475-2875-10-50 DO - 10.1186/1475-2875-10-50 ID - Nambozi2011 ER - TY - STD TI - EHO. Malaria in pregnancy. WHO Evidence Review Group meeting report. Geneva, World Health Organization. http://www.who.int/malaria/mpac/mpac-sept2015-erg-mip-report.pdf. 2015. UR - http://www.who.int/malaria/mpac/mpac-sept2015-erg-mip-report.pdf ID - ref36 ER - TY - JOUR AU - Manyando, C. AU - Mkandawire, R. AU - Puma, L. AU - Sinkala, M. AU - Mpabalwani, E. AU - Njunju, E. PY - 2010 DA - 2010// TI - Safety of artemether–lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia JO - Malar J. VL - 9 UR - https://doi.org/10.1186/1475-2875-9-249 DO - 10.1186/1475-2875-9-249 ID - Manyando2010 ER - TY - JOUR AU - Moore, B. R. AU - Salman, S. AU - Davis, T. M. PY - 2016 DA - 2016// TI - Treatment regimens for pregnant women with falciparum malaria JO - Expert Rev Anti Infect Ther. VL - 14 UR - https://doi.org/10.1080/14787210.2016.1202758 DO - 10.1080/14787210.2016.1202758 ID - Moore2016 ER - TY - JOUR AU - Mosha, D. AU - Mazuguni, F. AU - Mrema, S. AU - Sevene, E. AU - Abdulla, S. AU - Genton, B. PY - 2014 DA - 2014// TI - Safety of artemether–lumefantrine exposure in first trimester of pregnancy: an observational cohort JO - Malar J. VL - 13 UR - https://doi.org/10.1186/1475-2875-13-197 DO - 10.1186/1475-2875-13-197 ID - Mosha2014 ER - TY - JOUR AU - Piola, P. AU - Nabasumba, C. AU - Turyakira, E. AU - Dhorda, M. AU - Lindegardh, N. AU - Nyehangane, D. PY - 2010 DA - 2010// TI - Efficacy and safety of artemether–lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial JO - Lancet Infect Dis. VL - 10 UR - https://doi.org/10.1016/S1473-3099(10)70202-4 DO - 10.1016/S1473-3099(10)70202-4 ID - Piola2010 ER - TY - JOUR AU - Spangenberg, T. AU - Burrows, J. N. AU - Kowalczyk, P. AU - McDonald, S. AU - Wells, T. N. AU - Willis, P. PY - 2013 DA - 2013// TI - The open access malaria box: a drug discovery catalyst for neglected diseases JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0062906 DO - 10.1371/journal.pone.0062906 ID - Spangenberg2013 ER - TY - JOUR AU - Corey, V. C. AU - Lukens, A. K. AU - Istvan, E. S. AU - Lee, M. C. AU - Franco, V. AU - Magistrado, P. PY - 2016 DA - 2016// TI - A broad analysis of resistance development in the malaria parasite JO - Nat Commun. VL - 7 UR - https://doi.org/10.1038/ncomms11901 DO - 10.1038/ncomms11901 ID - Corey2016 ER - TY - JOUR AU - McCarthy, J. S. AU - Rückle, T. AU - Djeriou, E. AU - Cantalloube, C. AU - Ter-Minassian, D. AU - Baker, M. PY - 2016 DA - 2016// TI - A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study JO - Malar J. VL - 15 UR - https://doi.org/10.1186/s12936-016-1511-3 DO - 10.1186/s12936-016-1511-3 ID - McCarthy2016 ER - TY - JOUR AU - Sawa, P. AU - Shekalaghe, S. A. AU - Drakeley, C. J. AU - Sutherland, C. J. AU - Mweresa, C. K. AU - Baidjoe, A. Y. PY - 2013 DA - 2013// TI - Malaria transmission after artemether–lumefantrine and dihydroartemisinin–piperaquine: a randomized trial JO - J Infect Dis VL - 207 UR - https://doi.org/10.1093/infdis/jit077 DO - 10.1093/infdis/jit077 ID - Sawa2013 ER - TY - JOUR AU - Daher, W. AU - Biot, C. AU - Fandeur, T. AU - Jouin, H. AU - Pelinski, L. AU - Viscogliosi, E. PY - 2006 DA - 2006// TI - Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure JO - Malar J. VL - 5 UR - https://doi.org/10.1186/1475-2875-5-11 DO - 10.1186/1475-2875-5-11 ID - Daher2006 ER - TY - JOUR AU - Hamed, K. AU - Kuhen, K. PY - 2015 DA - 2015// TI - No robust evidence of lumefantrine resistance JO - Antimicrob Agents Chemother VL - 59 UR - https://doi.org/10.1128/AAC.00329-15 DO - 10.1128/AAC.00329-15 ID - Hamed2015 ER - TY - JOUR AU - Beck, H. P. AU - Wampfler, R. AU - Carter, N. AU - Koh, G. AU - Osorio, L. AU - Rueangweerayut, R. PY - 2016 DA - 2016// TI - Estimation of tafenoquine anti-relapse efficacy using Plasmodium vivax genotyping JO - J Infect Dis VL - 213 UR - https://doi.org/10.1093/infdis/jiv508 DO - 10.1093/infdis/jiv508 ID - Beck2016 ER - TY - JOUR AU - Rochford, R. AU - Ohrt, C. AU - Baresel, P. C. AU - Campo, B. AU - Sampath, A. AU - Magill, A. J. PY - 2013 DA - 2013// TI - Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity JO - Proc Natl Acad Sci USA VL - 110 UR - https://doi.org/10.1073/pnas.1310402110 DO - 10.1073/pnas.1310402110 ID - Rochford2013 ER - TY - JOUR AU - Wallis, R. S. AU - Maeurer, M. AU - Mwaba, P. AU - Chakaya, J. AU - Rustomjee, R. AU - Migliori, G. B. PY - 2016 DA - 2016// TI - Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers JO - Lancet Infect Dis. VL - 16 UR - https://doi.org/10.1016/S1473-3099(16)00070-0 DO - 10.1016/S1473-3099(16)00070-0 ID - Wallis2016 ER - TY - JOUR AU - Bhatti, A. B. AU - Usman, M. AU - Kandi, V. PY - 2016 DA - 2016// TI - Current scenario of HIV/AIDS, treatment options, and major challenges with compliance to antiretroviral therapy JO - Cureus. VL - 8 ID - Bhatti2016 ER - TY - JOUR AU - Du Pont-Thibodeau, G. AU - Joyal, J. S. AU - Lacroix, J. PY - 2014 DA - 2014// TI - Management of neonatal sepsis in term newborns JO - F1000Prime Rep. VL - 6 UR - https://doi.org/10.12703/P6-67 DO - 10.12703/P6-67 ID - Du Pont-Thibodeau2014 ER - TY - JOUR AU - Kateera, F. AU - Ingabire, C. M. AU - Hakizimana, E. AU - Kalinda, P. AU - Mens, P. F. AU - Grobusch, M. P. PY - 2015 DA - 2015// TI - Malaria, anaemia and under-nutrition: three frequently co-existing conditions among preschool children in rural Rwanda JO - Malar J. VL - 14 UR - https://doi.org/10.1186/s12936-015-0973-z DO - 10.1186/s12936-015-0973-z ID - Kateera2015 ER - TY - JOUR AU - Rosenke, K. AU - Adjemian, J. AU - Munster, V. J. AU - Marzi, A. AU - Falzarano, D. AU - Onyango, C. O. PY - 2016 DA - 2016// TI - Plasmodium parasitemia associated with increased survival in Ebola virus-infected patients JO - Clin Infect Dis VL - 63 UR - https://doi.org/10.1093/cid/ciw452 DO - 10.1093/cid/ciw452 ID - Rosenke2016 ER - TY - JOUR AU - Laishram, D. D. AU - Sutton, P. L. AU - Nanda, N. AU - Sharma, V. L. AU - Sobti, R. C. AU - Carlton, J. M. PY - 2012 DA - 2012// TI - The complexities of malaria disease manifestations with a focus on asymptomatic malaria JO - Malar J. VL - 11 UR - https://doi.org/10.1186/1475-2875-11-29 DO - 10.1186/1475-2875-11-29 ID - Laishram2012 ER - TY - JOUR AU - Kimani, J. AU - Phiri, K. AU - Kamiza, S. AU - Duparc, S. AU - Ayoub, A. AU - Rojo, R. PY - 2016 DA - 2016// TI - Efficacy and safety of azithromycin-chloroquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa: an open-label, randomized trial JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0157045 DO - 10.1371/journal.pone.0157045 ID - Kimani2016 ER - TY - JOUR AU - Malaria, H. e. m. i. n. g. w. a. y. J. PY - 2015 DA - 2015// TI - Fifteen years of interventions JO - Nature VL - 526 UR - https://doi.org/10.1038/526198a DO - 10.1038/526198a ID - Malaria2015 ER - TY - JOUR AU - Penny, M. A. AU - Verity, R. AU - Bever, C. A. AU - Sauboin, C. AU - Galactionova, K. AU - Flasche, S. PY - 2015 DA - 2015// TI - Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)00725-4 DO - 10.1016/S0140-6736(15)00725-4 ID - Penny2015 ER - TY - JOUR AU - Rts, S. PY - 2015 DA - 2015// TI - Clinical Trials Partnership. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial JO - Lancet VL - 386 UR - https://doi.org/10.1016/S0140-6736(15)60721-8 DO - 10.1016/S0140-6736(15)60721-8 ID - Rts2015 ER - TY - JOUR AU - Epstein, J. E. AU - Richie, T. L. PY - 2013 DA - 2013// TI - The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review JO - Curr Opin Infect Dis. VL - 26 ID - Epstein2013 ER - TY - JOUR AU - Gomez-Perez, G. P. AU - Legarda, A. AU - Munoz, J. AU - Sim, B. K. AU - Ballester, M. R. AU - Dobano, C. PY - 2015 DA - 2015// TI - Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naive volunteers: effect of injection volume and dose on infectivity rates JO - Malar J. VL - 14 UR - https://doi.org/10.1186/s12936-015-0817-x DO - 10.1186/s12936-015-0817-x ID - Gomez-Perez2015 ER - TY - JOUR AU - Lyke, K. E. AU - Laurens, M. B. AU - Strauss, K. AU - Adams, M. AU - Billingsley, P. F. AU - James, E. PY - 2015 DA - 2015// TI - Optimizing intradermal administration of cryopreserved Plasmodium falciparum sporozoites in controlled human malaria infection JO - Am J Trop Med Hyg VL - 93 UR - https://doi.org/10.4269/ajtmh.15-0341 DO - 10.4269/ajtmh.15-0341 ID - Lyke2015 ER - TY - JOUR AU - Talley, A. K. AU - Healy, S. A. AU - Finney, O. C. AU - Murphy, S. C. AU - Kublin, J. AU - Salas, C. J. PY - 2014 DA - 2014// TI - Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naive subjects at a new facility for sporozoite challenge JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0109654 DO - 10.1371/journal.pone.0109654 ID - Talley2014 ER - TY - JOUR AU - Spinner, C. D. AU - Boesecke, C. AU - Zink, A. AU - Jessen, H. AU - Stellbrink, H. J. AU - Rockstroh, J. K. PY - 2016 DA - 2016// TI - HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans JO - Infection VL - 44 UR - https://doi.org/10.1007/s15010-015-0850-2 DO - 10.1007/s15010-015-0850-2 ID - Spinner2016 ER - TY - JOUR AU - Margolis, D. A. AU - Boffito, M. PY - 2015 DA - 2015// TI - Long-acting antiviral agents for HIV treatment JO - Curr Opin HIV AIDS. VL - 10 UR - https://doi.org/10.1097/COH.0000000000000169 DO - 10.1097/COH.0000000000000169 ID - Margolis2015 ER - TY - STD TI - WHO. WHO policy recommendation: Seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva, World Health Organization. http://www.whoint/malaria/publications/atoz/who_smc_policy_recommendation/en/. 2012. UR - http://www.whoint/malaria/publications/atoz/who_smc_policy_recommendation/en/ ID - ref65 ER - TY - JOUR AU - Cairns, M. AU - Roca-Feltrer, A. AU - Garske, T. AU - Wilson, A. L. AU - Diallo, D. AU - Milligan, P. J. PY - 2012 DA - 2012// TI - Estimating the potential public health impact of seasonal malaria chemoprevention in African children JO - Nat Commun. VL - 3 UR - https://doi.org/10.1038/ncomms1879 DO - 10.1038/ncomms1879 ID - Cairns2012 ER - TY - JOUR AU - Noor, A. M. AU - Kibuchi, E. AU - Mitto, B. AU - Coulibaly, D. AU - Doumbo, O. K. AU - Snow, R. W. PY - 2015 DA - 2015// TI - Sub-national targeting of seasonal malaria chemoprevention in the Sahelian countries of the Nouakchott Initiative JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0136919 DO - 10.1371/journal.pone.0136919 ID - Noor2015 ER - TY - JOUR AU - Tagbor, H. AU - Antwi, G. D. AU - Acheampong, P. R. AU - Bart Plange, C. AU - Chandramohan, D. AU - Cairns, M. PY - 2016 DA - 2016// TI - Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial JO - Trop Med Int Health. VL - 21 UR - https://doi.org/10.1111/tmi.12642 DO - 10.1111/tmi.12642 ID - Tagbor2016 ER - TY - JOUR AU - Tine, R. C. AU - Ndour, C. T. AU - Faye, B. AU - Cairns, M. AU - Sylla, K. AU - Ndiaye, M. PY - 2014 DA - 2014// TI - Feasibility, safety and effectiveness of combining home based malaria management and seasonal malaria chemoprevention in children less than 10 years in Senegal: a cluster-randomised trial JO - Trans R Soc Trop Med Hyg VL - 108 UR - https://doi.org/10.1093/trstmh/trt103 DO - 10.1093/trstmh/trt103 ID - Tine2014 ER - TY - JOUR AU - Zongo, I. AU - Milligan, P. AU - Compaore, Y. D. AU - Some, A. F. AU - Greenwood, B. AU - Tarning, J. PY - 2015 DA - 2015// TI - Randomized noninferiority trial of dihydroartemisinin–piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for seasonal malaria chemoprevention in Burkina Faso JO - Antimicrob Agents Chemother VL - 59 UR - https://doi.org/10.1128/AAC.04923-14 DO - 10.1128/AAC.04923-14 ID - Zongo2015 ER - TY - JOUR AU - Matondo, S. I. AU - Temba, G. S. AU - Kavishe, A. A. AU - Kauki, J. S. AU - Kalinga, A. AU - Zwetselaar, M. PY - 2014 DA - 2014// TI - High levels of sulphadoxine–pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania JO - Malar J. VL - 13 UR - https://doi.org/10.1186/1475-2875-13-152 DO - 10.1186/1475-2875-13-152 ID - Matondo2014 ER - TY - STD TI - WHO. Guidelines for th treatment of malaria, Third edition. Geneva, World Health Organization. http://www.appswhoint/iris/bitstream/10665/162441/1/9789241549127_engpdf. 2015. UR - http://www.appswhoint/iris/bitstream/10665/162441/1/9789241549127_engpdf ID - ref72 ER - TY - JOUR AU - Milner, D. A. AU - Whitten, R. O. AU - Kamiza, S. AU - Carr, R. AU - Liomba, G. AU - Dzamalala, C. PY - 2014 DA - 2014// TI - The systemic pathology of cerebral malaria in African children JO - Front Cell Infect Microbiol. VL - 4 UR - https://doi.org/10.3389/fcimb.2014.00104 DO - 10.3389/fcimb.2014.00104 ID - Milner2014 ER - TY - JOUR AU - Dondorp, A. M. AU - Fanello, C. I. AU - Hendriksen, I. C. AU - Gomes, E. AU - Seni, A. AU - Chhaganlal, K. D. PY - 2010 DA - 2010// TI - Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)61924-1 DO - 10.1016/S0140-6736(10)61924-1 ID - Dondorp2010 ER - TY - JOUR AU - Dondorp, A. AU - Nosten, F. AU - Stepniewska, K. AU - Day, N. AU - White, N. PY - 2005 DA - 2005// TI - Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67176-0 DO - 10.1016/S0140-6736(05)67176-0 ID - Dondorp2005 ER - TY - JOUR AU - Kremsner, P. G. AU - Taylor, T. AU - Issifou, S. AU - Kombila, M. AU - Chimalizeni, Y. AU - Kawaza, K. PY - 2012 DA - 2012// TI - A simplified intravenous artesunate regimen for severe malaria JO - J Infect Dis VL - 205 UR - https://doi.org/10.1093/infdis/jir724 DO - 10.1093/infdis/jir724 ID - Kremsner2012 ER - TY - JOUR AU - Kremsner, P. G. AU - Adegnika, A. A. AU - Hounkpatin, A. B. AU - Zinsou, J. F. AU - Taylor, T. E. AU - Chimalizeni, Y. PY - 2016 DA - 2016// TI - Intramuscular srtesunate for severe malaria in African children: a multicenter randomized controlled trial JO - PLoS Med. VL - 13 UR - https://doi.org/10.1371/journal.pmed.1001938 DO - 10.1371/journal.pmed.1001938 ID - Kremsner2016 ER - TY - JOUR AU - Barrocas, A. M. AU - Cymet, T. PY - 2007 DA - 2007// TI - Cinchonism in a patient taking quinine for leg cramps JO - Compr Ther VL - 33 UR - https://doi.org/10.1007/s12019-007-0013-1 DO - 10.1007/s12019-007-0013-1 ID - Barrocas2007 ER - TY - JOUR AU - Wolf, L. R. AU - Otten, E. J. AU - Spadafora, M. P. PY - 1992 DA - 1992// TI - Cinchonism: two case reports and review of acute quinine toxicity and treatment JO - J Emerg Med VL - 10 UR - https://doi.org/10.1016/0736-4679(92)90336-R DO - 10.1016/0736-4679(92)90336-R ID - Wolf1992 ER - TY - JOUR PY - 2013 DA - 2013// TI - Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria—worldwide, 2010–2012 JO - MMWR Morb Mortal Wkly Rep VL - 62 ID - ref80 ER - TY - JOUR AU - Jaureguiberry, S. AU - Ndour, P. A. AU - Roussel, C. AU - Ader, F. AU - Safeukui, I. AU - Nguyen, M. PY - 2014 DA - 2014// TI - Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-02-555953 DO - 10.1182/blood-2014-02-555953 ID - Jaureguiberry2014 ER - TY - JOUR AU - Rolling, T. AU - Agbenyega, T. AU - Krishna, S. AU - Kremsner, P. G. AU - Cramer, J. P. PY - 2015 DA - 2015// TI - Delayed hemolysis after artesunate treatment of severe malaria—review of the literature and perspective JO - Travel Med Infect Dis. VL - 13 UR - https://doi.org/10.1016/j.tmaid.2015.03.003 DO - 10.1016/j.tmaid.2015.03.003 ID - Rolling2015 ER - TY - JOUR AU - Okebe, J. AU - Eisenhut, M. PY - 2014 DA - 2014// TI - Pre-referral rectal artesunate for severe malaria JO - Cochrane Database Syst Rev. VL - 5 ID - Okebe2014 ER - TY - JOUR AU - Ashley, E. A. AU - Dhorda, M. AU - Fairhurst, R. M. AU - Amaratunga, C. AU - Lim, P. AU - Suon, S. PY - 2014 DA - 2014// TI - Spread of artemisinin resistance in Plasmodium falciparum malaria JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1314981 DO - 10.1056/NEJMoa1314981 ID - Ashley2014 ER - TY - JOUR AU - Cheah, P. Y. AU - Parker, M. AU - Dondorp, A. M. PY - 2016 DA - 2016// TI - Development of drugs for severe malaria in children JO - Int Health. VL - 8 UR - https://doi.org/10.1093/inthealth/ihw038 DO - 10.1093/inthealth/ihw038 ID - Cheah2016 ER - TY - JOUR AU - Deng, X. AU - Duffy, S. P. AU - Myrand-Lapierre, M. E. AU - Matthews, K. AU - Santoso, A. T. AU - Du, Y. L. PY - 2015 DA - 2015// TI - Reduced deformability of parasitized red blood cells as a biomarker for anti-malarial drug efficacy JO - Malar J. VL - 14 UR - https://doi.org/10.1186/s12936-015-0957-z DO - 10.1186/s12936-015-0957-z ID - Deng2015 ER - TY - JOUR AU - Jimenez-Diaz, M. B. AU - Ebert, D. AU - Salinas, Y. AU - Pradhan, A. AU - Lehane, A. M. AU - Myrand-Lapierre, M. E. PY - 2014 DA - 2014// TI - (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium JO - Proc Natl Acad Sci USA. VL - 111 UR - https://doi.org/10.1073/pnas.1414221111 DO - 10.1073/pnas.1414221111 ID - Jimenez-Diaz2014 ER - TY - JOUR AU - Flannery, E. L. AU - McNamara, C. W. AU - Kim, S. W. AU - Kato, T. S. AU - Li, F. AU - Teng, C. H. PY - 2015 DA - 2015// TI - Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials JO - ACS Chem Biol VL - 10 UR - https://doi.org/10.1021/cb500616x DO - 10.1021/cb500616x ID - Flannery2015 ER - TY - JOUR AU - Spillman, N. J. AU - Kirk, K. PY - 2015 DA - 2015// TI - The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs JO - Int J Parasitol Drugs Drug Resist. VL - 5 UR - https://doi.org/10.1016/j.ijpddr.2015.07.001 DO - 10.1016/j.ijpddr.2015.07.001 ID - Spillman2015 ER - TY - JOUR AU - Telen, M. J. AU - Batchvarova, M. AU - Shan, S. AU - Bovee-Geurts, P. H. AU - Zennadi, R. AU - Leitgeb, A. PY - 2016 DA - 2016// TI - Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion JO - Br J Haematol VL - 175 UR - https://doi.org/10.1111/bjh.14303 DO - 10.1111/bjh.14303 ID - Telen2016 ER - TY - STD TI - Higgins SJ, Elphinstone RE, Kain KC. Adjunctive Therapies for Malaria. In Living Reference Work. Volume Encyclopedia of Malaria. Edited by Kremsner PG, Krishna S. New York: Springer New York; 2014: 1-18 ID - ref91 ER - TY - JOUR AU - Taylor, T. E. AU - Molyneux, M. E. PY - 2015 DA - 2015// TI - The pathogenesis of pediatric cerebral malaria: eye exams, autopsies, and neuroimaging JO - Ann N Y Acad Sci VL - 1342 UR - https://doi.org/10.1111/nyas.12690 DO - 10.1111/nyas.12690 ID - Taylor2015 ER - TY - JOUR AU - Gallego-Delgado, J. AU - Walther, T. AU - Rodriguez, A. PY - 2016 DA - 2016// TI - The high blood pressure-malaria protection hypothesis JO - Circ Res VL - 119 UR - https://doi.org/10.1161/CIRCRESAHA.116.309602 DO - 10.1161/CIRCRESAHA.116.309602 ID - Gallego-Delgado2016 ER - TY - JOUR AU - Dellicour, S. AU - Desai, M. AU - Aol, G. AU - Oneko, M. AU - Ouma, P. AU - Bigogo, G. PY - 2015 DA - 2015// TI - Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya JO - Malar J. VL - 14 UR - https://doi.org/10.1186/s12936-015-0950-6 DO - 10.1186/s12936-015-0950-6 ID - Dellicour2015 ER - TY - JOUR AU - McGready, R. AU - Lee, S. J. AU - Wiladphaingern, J. AU - Ashley, E. A. AU - Rijken, M. J. AU - Boel, M. PY - 2012 DA - 2012// TI - Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study JO - Lancet Infect Dis. VL - 12 UR - https://doi.org/10.1016/S1473-3099(11)70339-5 DO - 10.1016/S1473-3099(11)70339-5 ID - McGready2012 ER - TY - JOUR AU - Breitkreutz, J. AU - Boos, J. PY - 2007 DA - 2007// TI - Paediatric and geriatric drug delivery JO - Expert Opin Drug Deliv VL - 4 UR - https://doi.org/10.1517/17425247.4.1.37 DO - 10.1517/17425247.4.1.37 ID - Breitkreutz2007 ER - TY - JOUR AU - Baber, N. PY - 1994 DA - 1994// TI - International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) JO - Br J Clin Pharmacol VL - 37 UR - https://doi.org/10.1111/j.1365-2125.1994.tb05705.x DO - 10.1111/j.1365-2125.1994.tb05705.x ID - Baber1994 ER - TY - JOUR AU - Shimp, R. L. AU - Rowe, C. AU - Reiter, K. AU - Chen, B. AU - Nguyen, V. AU - Aebig, J. PY - 2013 DA - 2013// TI - Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle JO - Vaccine. VL - 31 UR - https://doi.org/10.1016/j.vaccine.2013.04.034 DO - 10.1016/j.vaccine.2013.04.034 ID - Shimp2013 ER - TY - JOUR AU - Lee, S. M. AU - Wu, C. K. AU - Plieskatt, J. AU - McAdams, D. H. AU - Miura, K. AU - Ockenhouse, C. PY - 2016 DA - 2016// TI - Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates JO - Malar J. VL - 15 UR - https://doi.org/10.1186/s12936-016-1464-6 DO - 10.1186/s12936-016-1464-6 ID - Lee2016 ER - TY - JOUR AU - Li, Y. AU - Leneghan, D. B. AU - Miura, K. AU - Nikolaeva, D. AU - Brian, I. J. AU - Dicks, M. D. PY - 2016 DA - 2016// TI - Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology JO - Sci Rep. VL - 6 UR - https://doi.org/10.1038/srep18848 DO - 10.1038/srep18848 ID - Li2016 ER - TY - JOUR AU - Kapulu, M. C. AU - Da, D. F. AU - Miura, K. AU - Li, Y. AU - Blagborough, A. M. AU - Churcher, T. S. PY - 2015 DA - 2015// TI - Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum JO - Sci Rep. VL - 5 UR - https://doi.org/10.1038/srep11193 DO - 10.1038/srep11193 ID - Kapulu2015 ER - TY - JOUR AU - Campo, B. AU - Vandal, O. AU - Wesche, D. L. AU - Burrows, J. N. PY - 2015 DA - 2015// TI - Killing the hypnozoite–drug discovery approaches to prevent relapse in Plasmodium vivax JO - Pathog Glob Health. VL - 109 UR - https://doi.org/10.1179/2047773215Y.0000000013 DO - 10.1179/2047773215Y.0000000013 ID - Campo2015 ER - TY - JOUR AU - Deeks, S. G. H. I. V. PY - 2012 DA - 2012// TI - Shock and kill JO - Nature VL - 487 UR - https://doi.org/10.1038/487439a DO - 10.1038/487439a ID - Deeks2012 ER - TY - JOUR AU - Savarino, A. AU - Mai, A. AU - Norelli, S. AU - Daker, S. AU - Valente, S. AU - Rotili, D. PY - 2009 DA - 2009// TI - “Shock and kill” effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence JO - Retrovirology. VL - 6 UR - https://doi.org/10.1186/1742-4690-6-52 DO - 10.1186/1742-4690-6-52 ID - Savarino2009 ER - TY - JOUR AU - Eziefula, A. C. AU - Bousema, T. AU - Yeung, S. AU - Kamya, M. AU - Owaraganise, A. AU - Gabagaya, G. PY - 2014 DA - 2014// TI - Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial JO - Lancet Infect Dis. VL - 14 UR - https://doi.org/10.1016/S1473-3099(13)70268-8 DO - 10.1016/S1473-3099(13)70268-8 ID - Eziefula2014 ER - TY - JOUR AU - Goncalves, B. P. AU - Tiono, A. B. AU - Ouedraogo, A. AU - Guelbeogo, W. M. AU - Bradley, J. AU - Nebie, I. PY - 2016 DA - 2016// TI - Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether–lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial JO - BMC Med VL - 14 UR - https://doi.org/10.1186/s12916-016-0581-y DO - 10.1186/s12916-016-0581-y ID - Goncalves2016 ER - TY - JOUR AU - Bousema, T. AU - Drakeley, C. PY - 2011 DA - 2011// TI - Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination JO - Clin Microbiol Rev VL - 24 UR - https://doi.org/10.1128/CMR.00051-10 DO - 10.1128/CMR.00051-10 ID - Bousema2011 ER - TY - JOUR AU - Lucantoni, L. AU - Fidock, D. A. AU - Avery, V. M. PY - 2016 DA - 2016// TI - A luciferase-based, high-throughput assay for screening and profiling transmission-blocking compounds against Plasmodium falciparum gametocytes JO - Antimicrob Agents Chemother VL - 60 UR - https://doi.org/10.1128/AAC.01949-15 DO - 10.1128/AAC.01949-15 ID - Lucantoni2016 ER - TY - JOUR AU - Nilsson, S. K. AU - Childs, L. M. AU - Buckee, C. AU - Marti, M. PY - 2015 DA - 2015// TI - Targeting human transmission biology for malaria elimination JO - PLoS Pathog VL - 11 UR - https://doi.org/10.1371/journal.ppat.1004871 DO - 10.1371/journal.ppat.1004871 ID - Nilsson2015 ER - TY - JOUR AU - Kobylinski, K. C. AU - Sylla, M. AU - Chapman, P. L. AU - Sarr, M. D. AU - Foy, B. D. PY - 2011 DA - 2011// TI - Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages JO - Am J Trop Med Hyg VL - 85 UR - https://doi.org/10.4269/ajtmh.2011.11-0160 DO - 10.4269/ajtmh.2011.11-0160 ID - Kobylinski2011 ER - TY - JOUR AU - Leroy, D. AU - Campo, B. AU - Ding, X. AU - Burrows, J. N. AU - Cherbuin, S. PY - 2014 DA - 2014// TI - Defining the biology component of the drug discovery strategy for malaria eradication JO - Trends Parasitol VL - 30 UR - https://doi.org/10.1016/j.pt.2014.07.004 DO - 10.1016/j.pt.2014.07.004 ID - Leroy2014 ER - TY - JOUR AU - Katsuno, K. AU - Burrows, J. N. AU - Duncan, K. AU - Hooft van Huijsduijnen, R. AU - Kaneko, T. AU - Kita, K. PY - 2015 DA - 2015// TI - Hit and lead criteria in drug discovery for infectious diseases of the developing world JO - Nat Rev Drug Discov. VL - 14 UR - https://doi.org/10.1038/nrd4683 DO - 10.1038/nrd4683 ID - Katsuno2015 ER - TY - STD TI - McCarthy JS, Sekuloski S, Griffin P, Elliott S, Marquart L, Jörg M, et al. A Phase IIa clinical trial to characterize the pharmacokinetic–pharmacodynamic relationship of piperaquine using the induced blood stage infection model. ASTMH Ann Meet. 2014; 152. http://tinyurl.com/z9ng9df UR - http://tinyurl.com/z9ng9df ID - ref113 ER - TY - JOUR AU - McCarthy, J. S. AU - Griffin, P. M. AU - Sekuloski, S. AU - Bright, A. T. AU - Rockett, R. AU - Looke, D. PY - 2013 DA - 2013// TI - Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers JO - J Infect Dis VL - 208 UR - https://doi.org/10.1093/infdis/jit394 DO - 10.1093/infdis/jit394 ID - McCarthy2013 ER - TY - JOUR AU - White, N. J. PY - 2013 DA - 2013// TI - Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.00287-13 DO - 10.1128/AAC.00287-13 ID - White2013 ER - TY - JOUR AU - Sanz, L. M. AU - Crespo, B. AU - De-Cozar, C. AU - Ding, X. C. AU - Llergo, J. L. AU - Burrows, J. N. PY - 2012 DA - 2012// TI - P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0030949 DO - 10.1371/journal.pone.0030949 ID - Sanz2012 ER - TY - JOUR AU - Linares, M. AU - Viera, S. AU - Crespo, B. AU - Franco, V. AU - Gomez-Lorenzo, M. G. AU - Jimenez-Diaz, M. B. PY - 2015 DA - 2015// TI - Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay JO - Malar J. VL - 14 UR - https://doi.org/10.1186/s12936-015-0962-2 DO - 10.1186/s12936-015-0962-2 ID - Linares2015 ER - TY - JOUR AU - Jiménez-Díaz, M. B. AU - Mulet, T. AU - Viera, S. AU - Gómez, V. AU - Garuti, H. AU - Ibáñez, J. PY - 2009 DA - 2009// TI - Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-SCID IL2Rγ-null mice engrafted with human erythrocytes JO - Antimicrob Agents Chemother VL - 53 UR - https://doi.org/10.1128/AAC.00519-09 DO - 10.1128/AAC.00519-09 ID - Jiménez-Díaz2009 ER - TY - JOUR AU - Stanisic, D. I. AU - Liu, X. Q. AU - De, S. L. AU - Batzloff, M. R. AU - Forbes, T. AU - Davis, C. B. PY - 2015 DA - 2015// TI - Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines JO - Malar J. VL - 14 UR - https://doi.org/10.1186/s12936-015-0663-x DO - 10.1186/s12936-015-0663-x ID - Stanisic2015 ER - TY - JOUR AU - Ndiaye, J. L. AU - Faye, B. AU - Diouf, A. M. AU - Kuete, T. AU - Cisse, M. AU - Seck, P. A. PY - 2008 DA - 2008// TI - Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria JO - Malar J. VL - 7 UR - https://doi.org/10.1186/1475-2875-7-16 DO - 10.1186/1475-2875-7-16 ID - Ndiaye2008 ER - TY - JOUR AU - Bakshi, R. P. AU - Nenortas, E. AU - Tripathi, A. K. AU - Sullivan, D. J. AU - Shapiro, T. A. PY - 2013 DA - 2013// TI - Model system to define pharmacokinetic requirements for antimalarial drug efficacy JO - Sci Transl Med. VL - 5 UR - https://doi.org/10.1126/scitranslmed.3006684 DO - 10.1126/scitranslmed.3006684 ID - Bakshi2013 ER - TY - JOUR AU - Pasay, C. J. AU - Rockett, R. AU - Sekuloski, S. AU - Griffin, P. AU - Marquart, L. AU - Peatey, C. PY - 2016 DA - 2016// TI - Piperaquine monotherapy of drug-susceptible Plasmodium falciparum infection results in rapid clearance of parasitemia but is followed by the appearance of gametocytemia JO - J Infect Dis VL - 214 UR - https://doi.org/10.1093/infdis/jiw128 DO - 10.1093/infdis/jiw128 ID - Pasay2016 ER - TY - JOUR AU - Kofi Ekue, J. M. AU - Ulrich, A. M. AU - Rwabwogo-Atenyi, J. AU - Sheth, U. K. PY - 1983 DA - 1983// TI - A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria JO - Bull World Health Organ VL - 61 ID - Kofi Ekue1983 ER - TY - JOUR AU - Leang, R. AU - Canavati, S. E. AU - Khim, N. AU - Vestergaard, L. S. AU - Borghini Fuhrer, I. AU - Kim, S. PY - 2016 DA - 2016// TI - Efficacy and safety of pyronaridine–artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in western Cambodia JO - Antimicrob Agents Chemother VL - 60 UR - https://doi.org/10.1128/AAC.00039-16 DO - 10.1128/AAC.00039-16 ID - Leang2016 ER - TY - JOUR AU - Dembele, L. AU - Franetich, J. F. AU - Lorthiois, A. AU - Gego, A. AU - Zeeman, A. M. AU - Kocken, C. H. PY - 2014 DA - 2014// TI - Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures JO - Nat Med VL - 20 UR - https://doi.org/10.1038/nm.3461 DO - 10.1038/nm.3461 ID - Dembele2014 ER - TY - JOUR AU - Zeeman, A. M. AU - Lakshminarayana, S. B. AU - Werff, N. AU - Klooster, E. J. AU - Voorberg-van der Wel, A. AU - Kondreddi, R. R. PY - 2016 DA - 2016// TI - PI4 kinase is a prophylactic but not radical curative target in Plasmodium vivax-type malaria parasites JO - Antimicrob Agents Chemother VL - 60 UR - https://doi.org/10.1128/AAC.03080-15 DO - 10.1128/AAC.03080-15 ID - Zeeman2016 ER - TY - JOUR AU - Khetani, S. R. AU - Bhatia, S. N. PY - 2008 DA - 2008// TI - Microscale culture of human liver cells for drug development JO - Nat Biotechnol VL - 26 UR - https://doi.org/10.1038/nbt1361 DO - 10.1038/nbt1361 ID - Khetani2008 ER - TY - JOUR AU - Sattabongkot, J. AU - Yimamnuaychoke, N. AU - Leelaudomlipi, S. AU - Rasameesoraj, M. AU - Jenwithisuk, R. AU - Coleman, R. E. PY - 2006 DA - 2006// TI - Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax JO - Am J Trop Med Hyg VL - 74 ID - Sattabongkot2006 ER - TY - JOUR AU - Hovlid, M. L. AU - Winzeler, E. A. PY - 2016 DA - 2016// TI - Phenotypic screens in antimalarial drug discovery JO - Trends Parasitol VL - 32 UR - https://doi.org/10.1016/j.pt.2016.04.014 DO - 10.1016/j.pt.2016.04.014 ID - Hovlid2016 ER - TY - JOUR AU - Ruben, A. AU - Awe, A. AU - Hoffman, S. L. AU - Sim, B. K. L. AU - Billingsley, P. F. AU - Manoj, A. PY - 2013 DA - 2013// TI - 157 Cryopreservation of Plasmodium falciparum sporozoites and Sanaria® PfSPZ vaccine JO - Cryobiology VL - 67 UR - https://doi.org/10.1016/j.cryobiol.2013.09.163 DO - 10.1016/j.cryobiol.2013.09.163 ID - Ruben2013 ER - TY - JOUR AU - Singh, N. AU - Barnes, S. J. AU - Jenwithisuk, R. AU - Sattabongkot, J. AU - Adams, J. H. PY - 2016 DA - 2016// TI - A simple and efficient method for cryopreservation and recovery of viable Plasmodium vivax and P. falciparum sporozoites JO - Parasitol Int. VL - 65 UR - https://doi.org/10.1016/j.parint.2015.12.003 DO - 10.1016/j.parint.2015.12.003 ID - Singh2016 ER - TY - JOUR AU - March, S. AU - Ng, S. AU - Velmurugan, S. AU - Galstian, A. AU - Shan, J. AU - Logan, D. J. PY - 2013 DA - 2013// TI - A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax JO - Cell Host Microbe VL - 14 UR - https://doi.org/10.1016/j.chom.2013.06.005 DO - 10.1016/j.chom.2013.06.005 ID - March2013 ER - TY - JOUR AU - Wells, T. N. AU - Burrows, J. N. AU - Baird, J. K. PY - 2010 DA - 2010// TI - Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination JO - Trends Parasitol VL - 26 UR - https://doi.org/10.1016/j.pt.2009.12.005 DO - 10.1016/j.pt.2009.12.005 ID - Wells2010 ER - TY - JOUR AU - Mikolajczak, S. A. AU - Vaughan, A. M. AU - Kangwanrangsan, N. AU - Roobsoong, W. AU - Fishbaugher, M. AU - Yimamnuaychok, N. PY - 2015 DA - 2015// TI - Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice JO - Cell Host Microbe VL - 17 UR - https://doi.org/10.1016/j.chom.2015.02.011 DO - 10.1016/j.chom.2015.02.011 ID - Mikolajczak2015 ER - TY - JOUR AU - Nelwan, E. J. AU - Ekawati, L. L. AU - Tjahjono, B. AU - Setiabudy, R. AU - Sutanto, I. AU - Chand, K. PY - 2015 DA - 2015// TI - Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia JO - BMC Med VL - 13 UR - https://doi.org/10.1186/s12916-015-0535-9 DO - 10.1186/s12916-015-0535-9 ID - Nelwan2015 ER - TY - JOUR AU - Green, J. A. AU - Patel, A. K. AU - Patel, B. R. AU - Hussaini, A. AU - Harrell, E. J. AU - McDonald, M. J. PY - 2014 DA - 2014// TI - Tafenoquine at therapeutic concentrations does not prolong fridericia-corrected QT interval in healthy subjects JO - J Clin Pharmacol VL - 54 UR - https://doi.org/10.1002/jcph.302 DO - 10.1002/jcph.302 ID - Green2014 ER - TY - JOUR AU - Llanos-Cuentas, A. AU - Lacerda, M. V. AU - Rueangweerayut, R. AU - Krudsood, S. AU - Gupta, S. K. AU - Kochar, S. K. PY - 2014 DA - 2014// TI - Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study JO - Lancet VL - 383 UR - https://doi.org/10.1016/S0140-6736(13)62568-4 DO - 10.1016/S0140-6736(13)62568-4 ID - Llanos-Cuentas2014 ER - TY - JOUR AU - Miller, J. L. AU - Murray, S. AU - Vaughan, A. M. AU - Harupa, A. AU - Sack, B. AU - Baldwin, M. PY - 2013 DA - 2013// TI - Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0060820 DO - 10.1371/journal.pone.0060820 ID - Miller2013 ER - TY - JOUR AU - Vaughan, A. M. AU - Kappe, S. H. AU - Ploss, A. AU - Mikolajczak, S. A. PY - 2012 DA - 2012// TI - Development of humanized mouse models to study human malaria parasite infection JO - Future Microbiol. VL - 7 UR - https://doi.org/10.2217/fmb.12.27 DO - 10.2217/fmb.12.27 ID - Vaughan2012 ER - TY - JOUR AU - Ghidelli-Disse, S. AU - Lafuente-Monasterio, M. J. AU - Waterson, D. AU - Witty, M. AU - Younis, Y. AU - Paquet, T. PY - 2014 DA - 2014// TI - Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics JO - Malar J. VL - 13 UR - https://doi.org/10.1186/1475-2875-13-S1-P38 DO - 10.1186/1475-2875-13-S1-P38 ID - Ghidelli-Disse2014 ER - TY - JOUR AU - Fasan, P. O. PY - 1970 DA - 1970// TI - Field trial of cycloguanil pamoate in the treatment and suppression of malaria in Nigerian school children: a preliminary report JO - Trans R Soc Trop Med Hyg VL - 64 UR - https://doi.org/10.1016/0035-9203(70)90103-3 DO - 10.1016/0035-9203(70)90103-3 ID - Fasan1970 ER - TY - JOUR AU - McGregor, I. A. AU - Williams, K. AU - Walker, G. H. AU - Rahman, A. K. PY - 1966 DA - 1966// TI - Cycloguanil pamoate in the treatment and suppression of malaria in the Gambia, West Africa JO - BMJ. VL - 1 UR - https://doi.org/10.1136/bmj.1.5489.695 DO - 10.1136/bmj.1.5489.695 ID - McGregor1966 ER - TY - JOUR AU - Wyber, R. AU - Taubert, K. AU - Marko, S. AU - Kaplan, E. L. PY - 2013 DA - 2013// TI - Benzathine penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement JO - Glob Heart. VL - 8 UR - https://doi.org/10.1016/j.gheart.2013.08.011 DO - 10.1016/j.gheart.2013.08.011 ID - Wyber2013 ER - TY - JOUR AU - Leang, R. AU - Khu, N. H. AU - Mukaka, M. AU - Debackere, M. AU - Tripura, R. AU - Kheang, S. T. PY - 2016 DA - 2016// TI - An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia JO - BMC Med VL - 14 UR - https://doi.org/10.1186/s12916-016-0701-8 DO - 10.1186/s12916-016-0701-8 ID - Leang2016 ER - TY - JOUR AU - Spence, P. J. AU - Jarra, W. AU - Levy, P. AU - Nahrendorf, W. AU - Langhorne, J. PY - 2012 DA - 2012// TI - Mosquito transmission of the rodent malaria parasite Plasmodium chabaudi JO - Malar J. VL - 11 UR - https://doi.org/10.1186/1475-2875-11-407 DO - 10.1186/1475-2875-11-407 ID - Spence2012 ER - TY - JOUR AU - Plouffe, D. M. AU - Wree, M. AU - Du, A. Y. AU - Meister, S. AU - Li, F. AU - Patra, K. PY - 2016 DA - 2016// TI - High-throughput assay and discovery of small molecules that interrupt malaria transmission JO - Cell Host Microbe VL - 19 UR - https://doi.org/10.1016/j.chom.2015.12.001 DO - 10.1016/j.chom.2015.12.001 ID - Plouffe2016 ER - TY - JOUR AU - Lucantoni, L. AU - Silvestrini, F. AU - Signore, M. AU - Siciliano, G. AU - Eldering, M. AU - Dechering, K. J. PY - 2015 DA - 2015// TI - A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds JO - Sci Rep. VL - 5 UR - https://doi.org/10.1038/srep16414 DO - 10.1038/srep16414 ID - Lucantoni2015 ER - TY - JOUR AU - Delves, M. J. AU - Straschil, U. AU - Ruecker, A. AU - Miguel-Blanco, C. AU - Marques, S. AU - Baum, J. PY - 2016 DA - 2016// TI - Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions JO - Nat Protoc VL - 11 UR - https://doi.org/10.1038/nprot.2016.096 DO - 10.1038/nprot.2016.096 ID - Delves2016 ER - TY - JOUR AU - Vos, M. W. AU - Stone, W. J. AU - Koolen, K. M. AU - Gemert, G. J. AU - Schaijk, B. AU - Leroy, D. PY - 2015 DA - 2015// TI - A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes JO - Sci Rep. VL - 5 UR - https://doi.org/10.1038/srep18704 DO - 10.1038/srep18704 ID - Vos2015 ER - TY - JOUR AU - Almela, M. J. AU - Lozano, S. AU - Lelievre, J. AU - Colmenarejo, G. AU - Coteron, J. M. AU - Rodrigues, J. PY - 2015 DA - 2015// TI - A new set of chemical starting points with Plasmodium falciparum transmission-blocking potential for antimalarial drug discovery JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0135139 DO - 10.1371/journal.pone.0135139 ID - Almela2015 ER - TY - JOUR AU - Delves, M. J. AU - Ruecker, A. AU - Straschil, U. AU - Lelievre, J. AU - Marques, S. AU - Lopez-Barragan, M. J. PY - 2013 DA - 2013// TI - Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.00325-13 DO - 10.1128/AAC.00325-13 ID - Delves2013 ER - TY - JOUR AU - Delves, M. AU - Plouffe, D. AU - Scheurer, C. AU - Meister, S. AU - Wittlin, S. AU - Winzeler, E. A. PY - 2012 DA - 2012// TI - The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites JO - PLoS Med. VL - 9 UR - https://doi.org/10.1371/journal.pmed.1001169 DO - 10.1371/journal.pmed.1001169 ID - Delves2012 ER - TY - JOUR AU - Makanga, M. PY - 2014 DA - 2014// TI - A review of the effects of artemether–lumefantrine on gametocyte carriage and disease transmission JO - Malar J. VL - 13 UR - https://doi.org/10.1186/1475-2875-13-291 DO - 10.1186/1475-2875-13-291 ID - Makanga2014 ER - TY - JOUR AU - Kern, S. E. AU - Tiono, A. B. AU - Makanga, M. AU - Gbadoe, A. D. AU - Premji, Z. AU - Gaye, O. PY - 2011 DA - 2011// TI - Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether–lumefantrine to reduce malaria disease burden: a modelling and simulation analysis JO - Malar J. VL - 10 UR - https://doi.org/10.1186/1475-2875-10-210 DO - 10.1186/1475-2875-10-210 ID - Kern2011 ER - TY - JOUR AU - Ogutu, B. AU - Tiono, A. B. AU - Makanga, M. AU - Premji, Z. AU - Gbadoe, A. D. AU - Ubben, D. PY - 2010 DA - 2010// TI - Treatment of asymptomatic carriers with artemether–lumefantrine: an opportunity to reduce the burden of malaria? JO - Malar J. VL - 9 UR - https://doi.org/10.1186/1475-2875-9-30 DO - 10.1186/1475-2875-9-30 ID - Ogutu2010 ER - TY - JOUR AU - Nunes, J. K. AU - Woods, C. AU - Carter, T. AU - Raphael, T. AU - Morin, M. J. AU - Diallo, D. PY - 2014 DA - 2014// TI - Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward JO - Vaccine. VL - 32 UR - https://doi.org/10.1016/j.vaccine.2014.07.030 DO - 10.1016/j.vaccine.2014.07.030 ID - Nunes2014 ER - TY - JOUR AU - Tiono, A. B. AU - Ouedraogo, A. AU - Ogutu, B. AU - Diarra, A. AU - Coulibaly, S. AU - Gansane, A. PY - 2013 DA - 2013// TI - A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso JO - Malar J. VL - 12 UR - https://doi.org/10.1186/1475-2875-12-79 DO - 10.1186/1475-2875-12-79 ID - Tiono2013 ER - TY - JOUR AU - Chaccour, C. AU - Barrio, A. AU - Gil Royo, A. G. AU - Martinez Urbistondo, D. AU - Slater, H. AU - Hammann, F. PY - 2015 DA - 2015// TI - Screening for an ivermectin slow-release formulation suitable for malaria vector control JO - Malar J. VL - 14 UR - https://doi.org/10.1186/s12936-015-0618-2 DO - 10.1186/s12936-015-0618-2 ID - Chaccour2015 ER - TY - JOUR AU - Ouédraogo, A. L. AU - Bastiaens, G. J. AU - Tiono, A. B. AU - Guelbeogo, W. M. AU - Kobylinski, K. C. AU - Ouedraogo, A. PY - 2015 DA - 2015// TI - Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial JO - Clin Infect Dis VL - 60 UR - https://doi.org/10.1093/cid/ciu797 DO - 10.1093/cid/ciu797 ID - Ouédraogo2015 ER - TY - JOUR AU - Tiono, A. B. AU - Dicko, A. AU - Ndububa, D. A. AU - Agbenyega, T. AU - Pitmang, S. AU - Awobusuyi, J. PY - 2009 DA - 2009// TI - Chlorproguanil–dapsone–artesunate versus chlorproguanil–dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria JO - Am J Trop Med Hyg VL - 81 UR - https://doi.org/10.4269/ajtmh.2009.09-0351 DO - 10.4269/ajtmh.2009.09-0351 ID - Tiono2009 ER - TY - JOUR AU - Premji, Z. AU - Umeh, R. E. AU - Owusu-Agyei, S. AU - Esamai, F. AU - Ezedinachi, E. U. AU - Oguche, S. PY - 2009 DA - 2009// TI - Chlorproguanil–dapsone–artesunate versus artemether–lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria JO - PLoS ONE VL - 4 UR - https://doi.org/10.1371/journal.pone.0006682 DO - 10.1371/journal.pone.0006682 ID - Premji2009 ER - TY - JOUR AU - Jamei, M. AU - Marciniak, S. AU - Feng, K. AU - Barnett, A. AU - Tucker, G. AU - Rostami-Hodjegan, A. PY - 2009 DA - 2009// TI - The Simcyp population-based ADME simulator JO - Expert Opin Drug Metab Toxicol. VL - 5 UR - https://doi.org/10.1517/17425250802691074 DO - 10.1517/17425250802691074 ID - Jamei2009 ER - TY - JOUR AU - Fairhurst, R. M. PY - 2015 DA - 2015// TI - High antimalarial efficacy of dihydroartemisinin–piperaquine on the China-Myanmar border: the calm before the storm JO - Am J Trop Med Hyg. VL - 93 UR - https://doi.org/10.4269/ajtmh.15-0349 DO - 10.4269/ajtmh.15-0349 ID - Fairhurst2015 ER - TY - JOUR AU - Chavchich, M. AU - Breda, K. AU - Rowcliffe, K. AU - Diagana, T. T. AU - Edstein, M. D. PY - 2015 DA - 2015// TI - The spiroindolone KAE609 does not induce dormant ring stages in Plasmodium falciparum parasites JO - Antimicrob Agents Chemother VL - 93 ID - Chavchich2015 ER - TY - JOUR AU - Teuscher, F. AU - Gatton, M. L. AU - Chen, N. AU - Peters, J. AU - Kyle, D. E. AU - Cheng, Q. PY - 2010 DA - 2010// TI - Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure JO - J Infect Dis VL - 202 UR - https://doi.org/10.1086/656476 DO - 10.1086/656476 ID - Teuscher2010 ER - TY - JOUR AU - Nosten, F. PY - 2010 DA - 2010// TI - Waking the sleeping beauty JO - J Infect Dis VL - 202 UR - https://doi.org/10.1086/656478 DO - 10.1086/656478 ID - Nosten2010 ER - TY - JOUR AU - Waring, M. J. AU - Arrowsmith, J. AU - Leach, A. R. AU - Leeson, P. D. AU - Mandrell, S. AU - Owen, R. M. PY - 2015 DA - 2015// TI - An analysis of the attrition of drug candidates from four major pharmaceutical companies JO - Nat Rev Drug Discov. VL - 14 UR - https://doi.org/10.1038/nrd4609 DO - 10.1038/nrd4609 ID - Waring2015 ER - TY - JOUR AU - Sonoiki, E. AU - Palencia, A. AU - Guo, D. AU - Ahyong, V. AU - Dong, C. AU - Li, X. PY - 2016 DA - 2016// TI - Anti-malarial benzoxaboroles target P. falciparum leucyl-tRNA synthetase JO - Antimicrob Agents Chemother VL - 60 UR - https://doi.org/10.1128/AAC.00820-16 DO - 10.1128/AAC.00820-16 ID - Sonoiki2016 ER - TY - JOUR AU - Zhang, B. AU - Watts, K. M. AU - Hodge, D. AU - Kemp, L. M. AU - Hunstad, D. A. AU - Hicks, L. M. PY - 2011 DA - 2011// TI - A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling JO - Biochemistry VL - 50 UR - https://doi.org/10.1021/bi200113y DO - 10.1021/bi200113y ID - Zhang2011 ER - TY - JOUR AU - Heidebrecht, R. W. AU - Mulrooney, C. AU - Austin, C. P. AU - Barker, R. H. AU - Beaudoin, J. A. AU - Cheng, K. C. PY - 2012 DA - 2012// TI - Diversity-oriented synthesis yields a novel lead for the treatment of malaria JO - ACS Med Chem Lett. VL - 3 UR - https://doi.org/10.1021/ml200244k DO - 10.1021/ml200244k ID - Heidebrecht2012 ER - TY - JOUR AU - Schuurman, J. AU - Graus, Y. F. AU - Labrijn, A. F. AU - Ruuls, S. AU - Parren, P. W. PY - 2014 DA - 2014// TI - Opening the door to innovation JO - MAbs VL - 6 UR - https://doi.org/10.4161/mabs.29004 DO - 10.4161/mabs.29004 ID - Schuurman2014 ER - TY - JOUR AU - Blaskovich, M. A. AU - Zuegg, J. AU - Elliott, A. G. AU - Cooper, M. A. PY - 2015 DA - 2015// TI - Helping chemists discover new antibiotics JO - ACS Infect Dis. VL - 1 UR - https://doi.org/10.1021/acsinfecdis.5b00044 DO - 10.1021/acsinfecdis.5b00044 ID - Blaskovich2015 ER - TY - JOUR AU - Batool, S. AU - Khan, Z. A. AU - Kamal, W. AU - Mushtaq, G. AU - Kamal, M. A. PY - 2015 DA - 2015// TI - In silico screening for identification of novel anti-malarial inhibitors by molecular docking, pharmacophore modeling and virtual screening JO - Med Chem VL - 11 UR - https://doi.org/10.2174/1573406411666150305113533 DO - 10.2174/1573406411666150305113533 ID - Batool2015 ER - TY - JOUR AU - Kuhen, K. L. AU - Chatterjee, A. K. AU - Rottmann, M. AU - Gagaring, K. AU - Borboa, R. AU - Buenviaje, J. PY - 2014 DA - 2014// TI - KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment and prevention of disease transmission JO - Antimicrob Agents Chemother VL - 58 UR - https://doi.org/10.1128/AAC.02727-13 DO - 10.1128/AAC.02727-13 ID - Kuhen2014 ER - TY - STD TI - From Aspiration to Action. What will it take to end malaria? http://www.endmalaria2040.org/. 2016. p. 1–31. UR - http://www.endmalaria2040.org/ ID - ref175 ER -